These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 37847349)

  • 1. Cutting-edge innovations in breast cancer diagnosis- the potential of HDMI biomarkers.
    Zahra K; Farooqi HA
    Clin Exp Metastasis; 2024 Feb; 41(1):77-78. PubMed ID: 37847349
    [No Abstract]   [Full Text] [Related]  

  • 2. Hybrid high-definition microvessel imaging/shear wave elastography improves breast lesion characterization.
    Gu J; Ternifi R; Larson NB; Carter JM; Boughey JC; Stan DL; Fazzio RT; Fatemi M; Alizad A
    Breast Cancer Res; 2022 Mar; 24(1):16. PubMed ID: 35248115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volumetric imaging and morphometric analysis of breast tumor angiogenesis using a new contrast-free ultrasound technique: a feasibility study.
    Gu J; Ternifi R; Sabeti S; Larson NB; Carter JM; Fazzio RT; Fatemi M; Alizad A
    Breast Cancer Res; 2022 Nov; 24(1):85. PubMed ID: 36451243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound high-definition microvasculature imaging with novel quantitative biomarkers improves breast cancer detection accuracy.
    Ternifi R; Wang Y; Gu J; Polley EC; Carter JM; Pruthi S; Boughey JC; Fazzio RT; Fatemi M; Alizad A
    Eur Radiol; 2022 Nov; 32(11):7448-7462. PubMed ID: 35486168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive prediction of axillary lymph node breast cancer metastasis using morphometric analysis of nodal tumor microvessels in a contrast-free ultrasound approach.
    Ferroni G; Sabeti S; Abdus-Shakur T; Scalise L; Carter JM; Fazzio RT; Larson NB; Fatemi M; Alizad A
    Breast Cancer Res; 2023 Jun; 25(1):65. PubMed ID: 37296471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine molecular applications and recent advances in breast cancer diagnostics.
    Pankotai-Bodó G; Oláh-Németh O; Sükösd F; Pankotai T
    J Biotechnol; 2024 Jan; 380():20-28. PubMed ID: 38122830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinase-substrate Edge Biomarkers Provide a More Accurate Prognostic Prediction in ER-negative Breast Cancer.
    Sun Y; Li C; Pang S; Yao Q; Chen L; Li Y; Zeng R
    Genomics Proteomics Bioinformatics; 2020 Oct; 18(5):525-538. PubMed ID: 33450402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutting-edge sonography obviates breast biopsy.
    Rubin E
    Diagn Imaging (San Franc); 1996 Sep; Suppl():AU14-6, AU32. PubMed ID: 10170151
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnosing phenotypes of single-sample individuals by edge biomarkers.
    Zhang W; Zeng T; Liu X; Chen L
    J Mol Cell Biol; 2015 Jun; 7(3):231-41. PubMed ID: 25917597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innovations and Challenges in Breast Cancer Care: A Review.
    Chopra S; Khosla M; Vidya R
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative Biomarkers for Cancer Detection Using Contrast-Free Ultrasound High-Definition Microvessel Imaging: Fractal Dimension, Murray's Deviation, Bifurcation Angle & Spatial Vascularity Pattern.
    Ternifi R; Wang Y; Polley EC; Fazzio RT; Fatemi M; Alizad A
    IEEE Trans Med Imaging; 2021 Dec; 40(12):3891-3900. PubMed ID: 34329160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinatorial Electrophoresis and Mass Spectrometry-Based Proteomics in Breast Milk for Breast Cancer Biomarker Discovery.
    Aslebagh R; Channaveerappa D; Pentecost BT; Arcaro KF; Darie CC
    Adv Exp Med Biol; 2019; 1140():451-467. PubMed ID: 31347064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latent space search based multimodal optimization with personalized edge-network biomarker for multi-purpose early disease prediction.
    Liang J; Li ZW; Sun ZN; Bi Y; Cheng H; Zeng T; Guo WF
    Brief Bioinform; 2023 Sep; 24(6):. PubMed ID: 37833844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular profiling: moving away from tumor philately.
    Reis-Filho JS; Weigelt B; Fumagalli D; Sotiriou C
    Sci Transl Med; 2010 Sep; 2(47):47ps43. PubMed ID: 20811040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive strategies for breast cancer early detection.
    Trecate G; Sinues PM; Orlandi R
    Future Oncol; 2016 Jun; 12(11):1395-411. PubMed ID: 27044539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision oncology for breast cancer through clinical trials.
    Blucher AS; Mills GB; Tsang YH
    Clin Exp Metastasis; 2022 Feb; 39(1):71-78. PubMed ID: 33950412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Developments in diagnostic imaging of breast cancer].
    Sawai Y; Nishi T; Inoue T; Yayoi E
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1352-6. PubMed ID: 17876130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robust edge-based biomarker discovery improves prediction of breast cancer metastasis.
    Adnan N; Lei C; Ruan J
    BMC Bioinformatics; 2020 Sep; 21(Suppl 14):359. PubMed ID: 32998692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-free miRNAs as non-invasive biomarkers in breast cancer: Significance in early diagnosis and metastasis prediction.
    Kashyap D; Kaur H
    Life Sci; 2020 Apr; 246():117417. PubMed ID: 32044304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of magnetic nanoparticles in the localization and treatment of breast cancer.
    Ahmed M; Douek M
    Biomed Res Int; 2013; 2013():281230. PubMed ID: 23936784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.